2007
DOI: 10.1002/pmic.200600836
|View full text |Cite
|
Sign up to set email alerts
|

Prevalidation of potential protein biomarkers in toxicology using iTRAQ™ reagent technology

Abstract: Today, toxicoproteomics still relies mainly on 2-DE followed by MS for detection and identification of proteins, which might characterize a certain state of disease, indicate toxicity or even predict carcinogenicity. We utilized the classical 2-DE/MS approach for the evaluation of early protein biomarkers which are predictive for chemically induced hepatocarcinogenesis in rats. We were able to identify statistically significantly deregulated proteins in N-nitrosomorpholine exposed rat liver tissue. Based on li… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

2
21
0

Year Published

2009
2009
2017
2017

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 41 publications
(23 citation statements)
references
References 36 publications
2
21
0
Order By: Relevance
“…Each pooled sample contained 40 µg protein. Protein Reduction, Alkylation and iTRAQ labeling were performed using an iTRAQ Reagent 4 Plex Kit according to standard procedures (Gluckmann et al, 2007). Pooled samples were labeled as described below: iTRAQ isobaric reagents 114, normal colon mucosa of mice in the vehicle control group; 115, colon mucosa of mice in the DSS control group; 116, colon mucosa of mice in the DSS and SNE-treated group; 117, colon mucosa of mice in the DSS and PE-treated group.…”
Section: Lc-ms/ms Analysismentioning
confidence: 99%
“…Each pooled sample contained 40 µg protein. Protein Reduction, Alkylation and iTRAQ labeling were performed using an iTRAQ Reagent 4 Plex Kit according to standard procedures (Gluckmann et al, 2007). Pooled samples were labeled as described below: iTRAQ isobaric reagents 114, normal colon mucosa of mice in the vehicle control group; 115, colon mucosa of mice in the DSS control group; 116, colon mucosa of mice in the DSS and SNE-treated group; 117, colon mucosa of mice in the DSS and PE-treated group.…”
Section: Lc-ms/ms Analysismentioning
confidence: 99%
“…For optimization studies, four aliquots (72 g protein content each) of an MCF-7 (EMEM/insulin culture) protein extract digest solution, spiked with standards after digestion but before SPEC-PTC18 clean-up (see above), were labeled with iTRAQ reagents 114, 115, 116, and 117, and mixed in a ratio of 0.2:1:1:5. Alternatively, different amounts (4,20,20, and 100 g) of the same cell extract were labeled with iTRAQ reagents and mixed in a ratio of 1:1:1:1, to generate the same final protein ratios of 0.2:1:1:5. In addition, three aliquots (5, 25, and 127 g) of a standard protein mix digest solution (0.5 M) were labeled with iTRAQ reagents 114, 116, and 117, and combined 1:1:1 to generate protein ratios of 0.2:1:5.…”
Section: Itraq Labelingmentioning
confidence: 99%
“…43 Liver fibrosis and cirrhosis are commonly studied using rat models [8] . Among the 44 liver fibrosis animal models, which are induced by bile duct ligation (BDL) [9] , ethanol 45 [10] , carbon tetrachloride (CCl4) [11] or thioacetamide (TAA) [12] , the intraperitoneally 46 TAA-injected rat model is widely used to induce liver fibrosis and cirrhosis and 47 consistently produces liver fibrosis and cirrhosis in rats with a histopathology that is more 48 similar to that of human liver fibrosis and cirrhosis [13][14][15] . In 1948, TAA was first reported 49 as a hepatotoxic agent [16] .…”
mentioning
confidence: 99%
“…http://dx.doi.org/10.1101/125120 doi: bioRxiv preprint first posted online Apr. 6, 2017; hepatitis [43] and is one of the potential hepatocarcinogenic biomarkers [44] . patients, which suggests that DJ-1 maybe a candidate prognostic biomarker of HCC [45] .…”
mentioning
confidence: 99%